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Abstract: Monodisperse maghemite nanoparticles, templated in novel, well-defined
pyrazole-containing norbornene-based block copolymers, provided a superparamagnetic
nanocomposite with high saturation magnetization at room temperature under an applied
magnetic field. The synthesis of the polymer nanocomposites and physical, morphological,
and magnetic chracaterization of the nanocomposites are reported. Micelle-encapsulated
superparamagnetic nanocomposites were generated for dispersal in aqueous medium. Their
stability in water in the presence of a magnetic field was investigated as was their
morphology and cell viability, strongly suggesting the potential of these superparamagnetic
polymer-based nanocomposites in certain biomedical imaging and associated applications.
Keywords: block copolymer; polymeric nanocomposite; maghemite; ROMP; chelating ligand

1. Introduction
There has been great interest in magnetic nanoparticles for a number of biomedical applications,
including medical diagnosis and imaging, magnetic separation, magnetic hyperthermia, and controlled
drug delivery [1–7] as well as for biomimetic applications [8–10], such as magnetically controlled
locomotion of artificial bacterial flagellar motors [11] and artificial muscles [12]. Magnetic resonance
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imaging (MRI) is a powerful 3D technique for noninvasive imaging (deeper penetration) of anatomic
and physicochemical details of tissue and blood flow and diagnosis of a number of diseases [13,14].
To improve MRI resolution and image quality several paramagnetic iron oxide nanoparticles, based on
Fe2O3 and Fe3O4 [15,16], have been employed as negative contrast agents in clinical trials [1,17–21].
Among these, newly developed ultrasmall superparamagnetic iron oxide (USPIO) is, perhaps, the most
promising because of its absence of magnetic hysteresis at ambient temperature, high magnetization
change under applied magnetic field, tunability of sizes of the nanoparticles, non-toxicity, and rapid
clearance from the organs [22–25]. USPIO enhances MRI images by decreasing the T1- and T2 - relaxation
behavior of the water molecules through interaction with the superparamagnetic iron oxide core, inducing
signal increases in T1-weighted images (T1-w) and signal reduction in T2-weighted-gradient-echo (T*2-w)
images [26–28]. Control of uniformity and stability of magnetic nanoparticles is often challenging due
to their inherent nature to form clusters, particularly for nano-sized particles given the tendency to reduce
surface energy. Thus, strategies to prepare stable magnetic nanoparticle dispersions are of significant
interest, e.g., via coating the nanoparticle surface with ligands that act to prevent agglomeration.
Ligands grafted to a polymer backbone offer a means to control stability as well as spatial
behavior [29]. An iron-binding, anchoring ligand (siderophore) is present in one block of the diblock
copolymer to chelate iron-oxide nanoparticles while the other block contains a steric stabilizing group
which helps isolate the magnetic nanoparticles from each other and facilitate dispersion. Our previous
success in formation of stable and well-dispersed maghemite (γ-Fe2O3)-polymer nanocomposites led to
the design of more effective ligand systems through exploiting the chemistry of the oxirane group [30,31].
There are several natural iron-protein complexes that play an important role in a number of
physiological processes, e.g., transferring [32,33], ferritin, and hemeproteins (e.g., hemoglobin,
myoglobin, neuroglobin), where stable bonding between iron (III or II) core and protoporphrin IX and
the imidazole group of the histidine protein residue forms. Here, we functionalized the oxirane with
the 2,3-dimethylpyrazole group, a very close analog of imidazole, to study the chelation behavior with
the iron-oxide nanoparticles for better stabilization compared to common chelating functional groups
such as -COOH, -OH, -NH2, phosphate. Ring opening metathesis polymerization (ROMP), a powerful
and broadly applicable method compared to other controlled living polymerization techniques, was
employed to synthesize highly functionalized block copolymers with low polydispersity to form
superparamagnetic nanocomposite [7,34–36].
We present a strategy for the synthesis of a novel norbornene-based diblock copolymer, via ROMP
of a functional monomer, and subsequent in situ generation and stabilization of maghemite
nanoparticles to form superparamagnetic nanocomposites. The polynorbornene backbone was selected
for its high thermal stability, optical transparency, low dielectric constant, and good mechanical
properties [37]. In addition, functionalized norbornene-based monomers are readily polymerizable,
which is thermodynamically favorable by releasing the strain in the monomer, by highly tolerant
Grubbs catalysts into low polydispersity copolymers with readily tailored block ratios. The block
copolymers design, contains “chelating groups” in one block to bind with the metal nanoparticles and
“steric-stabilizing” block in another block to prevent agglomeration, was preferred for the
nanocomposite generation. The anchoring group was synthesized by taking advantage of the versatility
of oxirane ring-opening by the heterocycle pyrazole, creating a ligand to stabilize maghemite
nanopaticles through strong coordination. The stable binding of this ligand system represents a
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significant advance over our previously reported materials [23,24]. Well-defined novel diblock
copolymers, containing 1:1 anchoring and steric stabilizing blocks, were characterized by NMR, gel
permeation chromatography (GPC), thermogravimetric analysis (TGA), and differential scanning
calorimetry (DSC). The ligand-stabilized organic-inorganic hybrid nanocomposites were prepared into
self-assembled 1:1 block copolymer matrix in situ by a non-hydrolytic procedure using Fe(CO)5 [31]
and morphology and particle nature were characterized with TEM, Electron diffraction pattern, SEM
and XRD. Magnetic measurements on the nanocomposite were performed using SQUID
magnetometer demonstrates the typical superparamagnetic properties with better magnetization in
presence of magnetic field.
For biomedical applications, biocompatibility along with aqueous dispersibility and stability of the
superparamagnetic nanocomposites are essential. PluronicTM copolymers are well known in the
pharmaceutical industry to improve the solubility of hydrophobic drugs [38] and to increase
biocompatibility and blood circulation time [39,40]. Pluronic F127 is a triblock polymer of
poly(ethylene oxide)-poly(propylene-oxide)-poly(ethylene oxide) (PEO-PPO-PEO), consisting of
70 wt% PEO. Stabilization of several types of nanoparticles by Pluronic F127 was reported to maintain
stable suspensions in a high ionic strength environment [41]. It is reported in literature that iron oxide
nanoparticles were stabilized in water by phase transfer from an organic medium while maintaining its
inherent magnetic properties for drug delivery purposes [42,43]. Pluronic F127 also provides
antifouling properties to prevent aggregation and protein adsorption along with recognition by
reticuloendothelial system (RES) [44]. But Pluronic F127 is a stabilizer of intermediate strength for
nanoparticles. Here, Pluronic F127 was chosen as a carrier to encapsulate the stable, new pyrazole block
copolymer-stabilized nanocomposites, to provide an aqueous dispersibility and biocompatibility [45]. The
magnetic nanocomposite was encapsulated with F127 to provide water dispersability, subsequent
determination of aqueous stability was examined by TEM. To assess cytotoxicity of the resulting
micelle-encapsulated magnetic nanocomposites, a cell viability assay was performed with Hela cells.
2. Experimental
2.1. General
2.1.1. Materials
Bis(tricyclohexylphosphine)-benzylideneruthenium dichloride Grubbs’ second generation catalyst,
3,5-dimethylpyrazole, Fe(CO)5 (99.9%), and trimethylamine N-oxide (98%), DMF were purchased
from Aldrich and used as received. CH2Cl2 and CHCl3 were dried over CaCl2 and distilled.
Tetrahydrofuran (THF) was distilled over sodium and benzophenone under N2 before use. All catalyst
solutions were prepared in a glovebox. Pluoronic F127 (Mw~12600) prill was purchased from BASF.
Promega CellTiter 96® AQueous One Solution Reagent was purchased from Fisher. Hela cells were
purchased from ATCC (America Type Culture Collection, Manssas, VA, USA). All cells were
incubated in Minimum Essential Media (MEM, Invitrogen, Carlsbad, CA, USA), supplemented with
10% fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville, GA, USA), 100 units/mL
penicillin-streptomycin (Atlanta Biologicals, Lawrenceville, GA, USA) and incubated at 37 °C in a
95% humidified atmosphere containing 5% CO2.
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2.1.2. Characterization
1

H NMR and 13C NMR spectra were acquired on a Varian spectrometer at 500 and 125 MHz,
respectively, using CDCl3 as the solvent for all monomers and polymers. Elemental analysis was
performed at Atlantic Microlab, Inc., Norcross, GA. All FTIR studies were done using a Perkin-Elmer
Spectrum One FTIR spectrometer from 4000 to 500 cm−1. Gel permeation chromatography (GPC) was
conducted with a Waters 2414 refractive index detector, Waters 2996 photodiode array, and Waters
1525 binary HPLC pump (THF as the mobile phase, flow rate of 1 mL/min) using Waters styragel
HR2 and HR5E columns, and polystyrene standards. Thermogravimetric analysis (TGA) was
performed with a TA Instruments model Q5000 TGA, from room temperature to 600 °C at 20 °C/min.
All samples were dried under vacuum for 2 days before measurement. Differential scanning
calorimetry (DSC) was conducted with a TA Instruments Q1000 DSC, from −10 to 120 °C at a rate of
10 °C/min. Transmission electron microscopy (TEM) was accomplished using a JEOL 1011 TEM,
operated at 100 kV. The samples were prepared by casting a thin film of nanocomposite on
carbon-coated copper TEM grids. Particles size distribution, on the base of the profile of randomly
selected quasi-spherically shaped particles, has been obtained using the ImageJ program. Selected area
electron diffraction patterns were also obtained. XRD (Geigerflex Rigaku2, 2θ = 0–80°, step = 0.05,
dwell (s) = 3) was used to obtain powder X-ray diffraction pattern spectra using Cu-Kα radiation
(λ = 0.154 nm). Noise corrections were made by using MDI Jade 7 software. The morphology of the
block copolymers and the nanocomposite in powder form (sputter coated on sample holder) were
examined by SEM (Zeiss ultra 55). Magnetic properties of the nanocomposites were measured using a
superconducting quantum interference device (SQUID) magnetometer from Quantum Design. All the
measurements were done in powder form of the sample after vacuum drying. The temperature
dependence of the magnetization was determined by zero field-cooled (ZFC) and field-cooled (FC)
measurements. The ZFC curve was obtained by cooling down to 4 K at zero magnetic fields and then
measuring the magnetization under a 500 Oe applied magnetic field upto 300 K. The corresponding
FC curves were similarly obtained, except that this time the sample was cooled while applying a
500 Oe magnetic field. The magnetizations as a function of applied magnetic field were also studied at
100 K above the blocking temperature.
2.1.3. Cytotoxicity (MTS) Assay
To test the cytotoxicity of the nanoparticles, 4 × 103 per well of Hela cells in 96-well plates were
incubated in 90 µL of RPMI medium without phenol red, supplemented with 10% FBS and
100 units/mL penicillin-streptomycin for 24 h. Then the cells were incubated with various amounts of
nanoparticles (1 µg/mL, 10 µg/mL, 20 µg/mL, 50 µg/mL) for additional 20 h. Subsequently, 20 µL of
CellTiter 96® AQueous One Solution reagent was added into each well, followed by further incubation
for 4 h at 37 °C. The relative viability of the cells incubated with nanoparticles to untreated cells was
determined by measuring the MTS-formazan absorbance on a Kinetic microplate reader (Spectra Max
M5, Molecular Devices, Sunnyvale, CA, USA) at 490 nm with a subtraction of the absorbance of
cell-free blank volume at 490 nm. The results from three individual experiments were averaged.
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2.2. Synthesis of 3-(3,5-Dimethyl-1H-Pyrazol-1-yl)-2-Hydroxypropyl Bicyclo[2.2.1]
Hept-5-Ene-2-Carboxylate (2)
Monomer 1 was prepared according to our previous published procedure [46]. Epoxy monomer 1
(0.23 g, 1.2 mmol) in DMF was added dropwise to a suspension of 3,5-dimethylpyrazole (0.107 g,
1.11 mmol) and anhydrous potassium carbonate (0.166 g, 1.2 mmol) in 10 mL of anhydrous DMF.
The reaction was stirred at 100 °C for 9 h until the disappearance of starting materials (followed by
TLC). It was then cooled to room temperature, the salt was filtered off, and the solvent was removed
under reduced pressure. A wheatish creamy solid (0.15 g, 55% yield) was obtained after column
chromatography (1:1 hexane:ethyl acetate on silica) followed by vacuum drying overnight. 1H NMR
(500 MHz, CDCl3) δ: 6.14–6.03 (m, 1.5H, HC=CH), 5.87 (m, 0.5H, HC=CH), 5.74 (s, 1H-Py ring),
4.52 (b, 1H, -OH), 4.17–3.85 (m, 6H), 3.15 (s, 0.5H), 2.98–2.90 (m, 1H), 2.89–2.86 (m, 1H),
2.20–2.13 (m, 6H, 2 -CH3 in Py ring), 1.88–1.84 (s, 1H), 1.69–1.19 (m, 3H). 13C NMR (125 MHz,
CDCl3) δ: 176.05, 174.54, (C=O exo and endo) 148.24, 139.80, 138.14, 137.96, 137.92, 135.64,
132.26, 105.12 (=C-CH=C), 69.24, 65.19, 65.17, 65.04, 64.97, 49.72, 46.67, 46.36, 45.80, 45.77,
43.26, 43.04, 42.53, 41.64, 30.45, 29.31, 13.43 (Py-CH3), 10.95 (Py-CH3) IR (neat): 3349.48 (b, -OH),
3025.81 (=C-H stretch), 2925.08, 1732.36 (vs., C=O), 1601.25 (-C=C- stretch),1553.78 (-C=N-),
1492.89, 1452.06, 1333.81, 1272.80, 1232.39, 1180.06, 1029.02, 906.84, 756.10, 620.99 (-C=C- bend),
540.10 cm−1. Anal. calcd for C16H22N2O3: C, 66.18, H, 7.64. Found: C, 65.96, H, 7.65.
2.3. Synthesis of Diblock Copolymer 5 by ROMP of 3-(3,5-Dimethyl-1H-Pyrazol-1-yl)-2-Hydroxypropyl
Bicyclo[2.2.1]Hept-5-Ene-2-Carboxylate (5)
ROMP of monomer 2 with Grubbs second generation catalyst 3 was performed as shown in
Scheme 1. The glassware was dried and purged with vacuum and N2 in a Schlenk line several times
prior to conducting the polymerization reaction. A solution (0.2 M) of monomer 2 (120 mg, 4.13 × 10−4 M,
175 eq) was prepared in dry CH2Cl2 under N2. The catalyst solution was prepared by dissolving the
catalyst in anhydrous CH2Cl2 under N2 in a glovebox. The catalyst solution (2 mg, 2.36 × 10−6 M in
0.5 mL CH2Cl2, 1 eq) was added to the reaction mixture and stirred for 8 h at 30 °C. A norbornene
solution (38 mg, 4.13 × 10−4 M, 175 eq) was injected and stirred for another 9 h. The polymerization
reaction mixture was terminated with excess ethyl vinyl ether (300 eq relative to catalyst) and stirred for
another 1 h. The reaction mixture was then poured into cold methanol and stirred, purified, and dried under
vacuum, yielding a flaky white solid in 72% yield. 1H NMR (500 MHz, CDCl3) δ: 5.82 (b, CH, Py ring),
5.35–5.22 (b, -HC=CH-), 4.17–3.85, 3.18, 2.96, 2.44, 2.23–2.19, 1.87–1.27(b).
2.4. Stabilized Magnetic Dispersions
Preparation of monodisperse maghemite nanoparticles within copolymer matrices was accomplished
by our previously reported method [30] using cyclohexanone as solvent or others as required.
2.5. Micelles Stabilized Magnetic Nanoparticle Dispersions in Water
120 mg of F127 was dissolved in 20 mL (the concentration is higher than critical micelle
concentrations (CMC); CMC of Pluronic F127 is 0.007 g/cm3 at room temperature) [36,38,39,47,48] of
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water by vigorously stirring for 3 hrs. Maghemite-polymer nanocomposites (7 mg) were dispersed in
CH2Cl2. Equal volume of these two mixtures were added together and stirred under N2 at 40 °C
(waterbath) for until all CH2Cl2 evaporated in a fume hude and nanocomposite covered by the F127
coating was prepared in water. Then, it was subjected to centrifuge and finally, the light brown colored
supernatant was collected which contains block copolymer-maghemite nanocomposites entrapped in
pluronic micelles.
3. Results and Discussion
3.1. Synthesis of Monomer and Polymers
Scheme 1. Synthesis of monomers and block copolymers.

The monomer and polymers were designed and prepared by exploiting the versatility of epoxy
precursor 1. In the first step, pyrazole-containing monomer 2 was synthesized from 1 [46], by opening
the epoxide ring with 3,5-dimethyl pyrazole in the presence of base. Next, both a homopolymer 4 and
a 1:1 diblock copolymer 5 were synthesized according to Scheme 1 via ROMP using Grubbs second
generation catalyst (3, bis(tricyclohexylphosphine)-benzylideneruthenium dichloride). Copolymer 5
was prepared by sequential addition of monomer 2 and nobornene. The molecular weight and
polydispersity of the polymers (Table 1) were controlled on the basis of a time-dependent study,
monitoring monomer consumption by 1H NMR and controlling the [M]/[I] ratio, where M is monomer
and I is initiator.
The diblock copolymer template 5 contained the ligand system in one block that can chelate
through both N-(from pyrazole) and O-donors (from ring-opened hydroxy and/or carboxylate groups)
with the metal oxide core, while the second block contained the steric stabilizing group to disperse the
nanoparticle composite and reduce interaction between nanoparticles. The pyrazole ligands played a
vital role in stabilizing the maghemite nanoparticles, affording a supramolecular metal-organic hybrid.
The polymers were characterized by 1H NMR (Figure 1) and FTIR. In the 1H NMR, distinct peaks at
6.14–5.87 ppm for -CH=CH- vinyl protons, 5.74 ppm for -H pyrazole ring and a broad -OH proton
peak at 4.52 ppm were present for the monomer (Figure 1a) while the vinyl protons disappear and a
new peak appears at 5.35–5.22 ppm for new alkene protons for the polymers Figure 1(b,c).The ratio
between the alkene proton vs. pyrazole ring proton present in polymer determined the block ratio
(m:n). The molecular weights of the polymers were experimentally determined by standard GPC
(Figure 2) method calibrated with PS standards correspond to apparent Mn values, shown in Table1.
The relatively high polydispersity index of the copolymer is possibly due to the presence of
heteroatom (N, O) in the pendant group functionality.
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Table 1. Properties of the polymers.
Mn a
(Theo)
58072
67291

Block ratio
(m:n)
200:0 (4)
175:175 (5)

Mn b
(Exp)
65085
66331

m:n
1H NMR
1:0
1.08:1

PDI

Block
Ratio c
224:0
176:163

b

1.42
1.33

Td
(°C)
170
217

Tg
(°C)
46
39

a

: Theoretical molecular weight calculated from[M]/[I]feed; b: Mn and PDI were obtained experimentally
from gel permeation chromatography (GPC) in THF relative to polystyrene standards; c: Actual polymer
block ratio was calculated from the 1H NMR and GPC results; d: Temperature at 10% weight loss.

The glass transition temperature and thermal decomposition temperature were determined by DSC
and TGA analyses, respectively (Table 1). The 1:1 block copolymer 5 was more thermally stable
(decomposition at 217 °C) compare to the pyrazole group containing homopolymer 4. Because of the
thermally labile bond at the side chain, it was noticed, that the thermal stability of the polymer in
general decreases with respect to homopolynorbornene (450 °C) or epoxy containing homopolymer
(370 °C) as reported before [30]. The glass transition temperature of the polynorbornene, homopolymer, 4,
and copolymer, 5 (were approximately 31, 46, and 39 °C respectively), were in close range and broad
in nature.
Figure 1. 1H NMR analysis supporting the formation of 1:1 diblock copolymer;
(a) monomer 3; (b) homopolymer 4; and (c) 1:1 diblock copolymer 5.

(c)
3

(b)
2

(a)
1

8.0

7.5

7.0

6.5

6.0

5.5

5.0

4.5
f 1 (ppm)

ppm

4.0

3.5

3.0

2.5

2.0

1.5

1.0

Polymers 2012, 4

1218

Figure 2. Gel permeation chromatography (GPC) analysis of the polymers
(a) homopolymer 4; and (b) 1:1 diblock copolymer 5; (c) thermogravimetric analysis
(TGA) of the polymers.

3.2. Synthesis and Characterization of Polymeric-Iron Oxide Nanocomposite
The second step was to generate relatively uniform, highly crystalline maghemite nanoparticles
in situ from Fe(CO)5 precursor in the presence of diblock copolymer 5 (0.68% molar wt of polymer
compared to ironpentacarbonyl feed) in cyclohexanone. Supported by our previous study [31], 1:1
block copolymer ratio of the polymer was chosen to stabilize the nanopartcle stabilization at the
optimum level. Trimethylamine N-oxide was used as an oxidizer to prepare the maghemite
nanocomposite in a similar manner to our previously reported method [30,31]. Briefly, the block
copolymer and iron-pentacarbonyl were added in cyclohexanone and refluxed under inert atmosphere
until the solution turned to black. Thereafter, solution was cooled to room temperature and oxidizer
was added to it, followed by reflux for another few hours, and then, purified as mentioned in literature.
Finally, the nanocomposite was dispersed in solvent as required.
The block copolymer-stabilized nanocomposites were characterized by TEM, SEM, XRD, and
FTIR. TEM (Figure 3a) confirmed generation of relatively uniform and spherical iron oxide
nanoparticles. The size distribution (Figure 3b) of the nanoparticles was in the 3–6 nm range with an
average size of 4.3 nm. Evidence of formation of a crystalline structure of the Fe2O3 nanoparticles was
obtained by SAED and XRD (Figure 3(c,d)), revealing cubic maghemite-C type structures of the
nanoparticles, corresponding well with standard data [49]. The average diameter (d) of the singular
γ-Fe2O3 nanocrystallites, estimated using the Scherrer equation [50], was 4 nm, corresponding to the
strongest reflection (311) of Fe2O3 nanoparticles at 2θ value of 35.72°. This was in good agreement
with TEM results. SEM data revealed the bulk morphology of the 1:1 block copolymer and
nanocomposite. FTIR spectroscopic analysis provided compelling evidence of ligand-mediated
binding of iron oxide with the pendant chelating group of the diblock copolymer (Figure 3e). The
presence of a single, broad band at about 574 cm−1 in the FTIR spectrum of the nanocomposite is
characteristic of Fe-O stretching for less than 8 nm nanoparticles [51]. Also, the shift from 1732 cm−1
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to 1690 cm−1, corresponding to C=O stretching in the polymer and nanocomposite, respectively,
supported interaction between the iron oxide core and the diblock copolymer.
Figure 3. (a) TEM images of magnetic nanocomposite; (b) TEM nanoparticle size
distribution histogram; (c) electron diffraction pattern of nanocomposite; (d) XRD analysis
showing the presence of crystalline maghemite-C (NC-2); (e) FTIR analysis of 1:1 block
copolymer (labeled 5) and magnetic nanocomposite (labeled NC).
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3.3. Magnetic Properties of Nanocomposite
Magnetization (M) measurement as a function of temperature (T) was performed on γ-Fe2O3-diblock
copolymer nanocomposites in powder form using SQUID. Figure 4a shows the zero field cooled
(ZFC) and field cooled (FC) vs. temperature profile, where the blocking temperature (TB) of 9 K is
denoted by the peak of the ZFC curve. The low and sharp blocking temperature of the nanocomposite
is consistent with the small and uniform size of the maghemite nanoparticles, respectively. Uniform
distribution of the magnetic nanoparticles within the polymer matrix is further strengthened by very
close superimposition of the ZFC and FC curves after passing the TB. The magnetic hysteresis loop at
4.2 K, below TB, is shown in Figure 4b. The coercive field was of the order of 100 Oe. Above TB the
coercive field was zero and the data collapse onto the same curve when plotted as a function of H/T.
This H/T scaling behavior indicates that the sample consists of non-interacting superparamagnetic
particles. The magnetization data above TB are fit to a Langevin function, and a saturated moment of
approximately 73 emu/g is determined from the fit.
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Figure 4. (a) magnetization (M) vs. temperature (T) of the nanocomposite at 500 Oe
applied magnetic field (H); (b) M-H loop below TB shows coercive field (Hc) of 100 Oe;
(c) M- H loop above TB, coercive field (Hc) is zero.
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3.4. Formation of Biocompatible Nanocomposite
For potential biomedical applications, the stable dispersion in aqueous and physiological media, and
biocompatibility of the pyrazole-containing block copolymer-stabilized maghemite nanocomposites
was assessed. The organic soluble maghemite-polymer nanocomposites were dispersed in water using
Pluoronic F127 (PEO-PPO-PEO), using to a solvent evaporation method. The Pluronic-coated,
water-dispersible nanocomposite was generated by mixing an equal volume of the nanocomposite in
CH2Cl2 with an aqueous solution of Pluronic F127, followed by vigorous stirring and evaporation of
the CH2Cl2. The outer hydrophilic (PEO) blocks of Pluronic F127 help to form micelles and dispersion
in water while the hydrophobic block (PPO) attracts the polymer-coated maghemite nanoparticles. An
aqueous dispersion of micelle-encapsulated superparamagnetic nanocomposites was stable for weeks
and retained their magnetic properties.
The morphology of the Pluronic-pyrazole-maghemite nanocomposites in water was studied by
TEM (Figure 5a and 5b), indicating that the size of the core maghemite nanoparticles was similar
before and after dispersion in water (confirming that the particles were stable and did not aggregate).
The observed stability of the Pluronic-coated magnetic nanocomposites in water is important for
biological use and was consistent to literature reports [45,52].
For potential biomedical applications, the cytotoxicity of Pluronic-pyrazole block copolymer-coated
superparamagnetic nanoparticles was assessed using a cell viability assay with Hela cells. Hela cells
were incubated for 20 h with varying concentrations of the nanocomposites (0–50 µM), exhibiting
high cell viability, 90–100%, depending on concentration. Qin et al. reported a novel type ferrogel
(SPIONS coated with oleic acid and PF127) to release drug for magnetically controlled release of
hydrophobic drug very efficiently [42]. Recently, Zhao et al. also demonstrated a RGD modified
ferrogel, where of SPION is encapsulated in PF127, alginate and AAD, for sustain release of cells and
other bioactive agents under magnetic field [53]. Thus, the Pluronic encapsulated pyrazole block
copolymer stabilized iron oxide nanocomposite also provides a promising tool to encapsulate
hydrophobic drug or optical contrast agent and holds the potential for dual imaging modalities or
theranostic applications in biomedical field.
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Figure 5. (a) TEM image of Pluronic 127-coated polymer-maghemite nanocomposites;
(b) TEM nanoparticle size distribution histogram; (c) photograph of Pluronic
127-stabilized polymer-Fe2O3 nanocomposite without (left) and with external applied
magnetic field (right); and (d) cell viability of Pluronic 127-stabilized polymer-Fe2O3
nanocomposite incubated in Hela cells for 20 h as a function of concentration.
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4. Conclusions
In summary, it is clear that well-defined N,N-dimethyl pyrazole-functionalized norbornene-based
diblock copolymers are effective in stabilizing in situ-generated maghemite nanoparticles. The
resulting nanocomposite exhibited strong superparamagnetism in the presence of an external
magnetic field. Nanoparticle agglomeration was prevented through specific binding between the
pendant ligands in the anchoring block and the iron oxide metal core. This organic block
copolymer-inorganic maghemite nanocomposite underwent dynamic changes in magnetic
properties and directional motion in response to an external magnetic field without destroying the
integrity of the system. Pluronic127-coated magnetic nanocomposites were stable in aqueous
media and possessed low cytotoxicity, making them potential candidates as contrast agents for
MRI imaging, a carrier for drug delivery, or for use in magnetically-actuated biomimetic devices,
subjects of future investigation.
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